Guardant Health, Inc. (GH)
Health Care ยท Services-Medical Laboratories
Guardant Health, Inc. (GH) is listed on Nasdaq, where its shares have traded since October 4, 2018. SentiSense covers Guardant Health, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. Helmy Eltoukhy is its chief executive officer. The company reports 2,506 employees, and its corporate website is www.guardanthealth.com.
About Guardant Health, Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Latest reported results
Guardant Health Inc. reported revenue of $361.0 million for Q3 FY2026, up 36.1% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 584 institutions reported holding GH, with 133.8 million shares worth $20.0 billion in aggregate. The largest reported holders were Vanguard, BlackRock and T. Rowe Price. Of the 5 largest reported holders, 1 added shares and 4 reduced their positions during the quarter.
More on GH
- GH sentiment: whether news and social coverage of Guardant Health, Inc. leans bullish or bearish, and the stories driving it.
- GH ownership: all 584 reporting institutions, plus insider and congressional trades.
- GH financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Guardant Health, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Guardant Health, Inc. do?
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use.
What sector is GH in?
SentiSense classifies Guardant Health, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does GH stock trade?
Guardant Health, Inc. (GH) is listed on Nasdaq, where its shares have traded since October 4, 2018.
Who is the CEO of Guardant Health, Inc.?
Helmy Eltoukhy is the chief executive officer of Guardant Health, Inc..